1-(1-ADAMANTYL)AZEPAN-2-ONE
![]() |
- $237 - $527
- Product name: 1-(1-ADAMANTYL)AZEPAN-2-ONE
- CAS: 3716-64-1
- MF: C16H25NO
- MW: 247.38
- EINECS:
- MDL Number:MFCD01882091
- Synonyms:1-(1-ADAMANTYL)AZEPAN-2-ONE;2H-azepin-2-one, hexahydro-1-tricyclo[3.3.1.1~3,7~]dec-1-y;2H-Azepin-2-one, hexahydro-1-tricyclo[3.3.1.13,7]dec-1-yl-
5 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
- Matrix Scientific
Package
- 5MG
- 500mg
- 5g
- ManufacturerAK Scientific
- Product number1836AE
- Product description1-(1-Adamantyl)azepan-2-one
- Packaging500mg
- Price$369
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0306821
- Product description1-(1-ADAMANTYL)AZEPAN-2-ONE 95.00%
- Packaging5MG
- Price$502.78
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM291535
- Product description1-(Adamantan-1-yl)azepan-2-one 97%
- Packaging5g
- Price$497
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11133905
- Product description1-(Adamantan-1-yl)azepan-2-one 97%
- Packaging5g
- Price$527
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number063690
- Product description1-(1-Adamantyl)azepan-2-one
- Packaging500mg
- Price$237
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 1836AE | 1-(1-Adamantyl)azepan-2-one | 500mg | $369 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | CHM0306821 | 1-(1-ADAMANTYL)AZEPAN-2-ONE 95.00% | 5MG | $502.78 | 2021-12-16 | Buy |
Chemenu | CM291535 | 1-(Adamantan-1-yl)azepan-2-one 97% | 5g | $497 | 2021-12-16 | Buy |
Crysdot | CD11133905 | 1-(Adamantan-1-yl)azepan-2-one 97% | 5g | $527 | 2021-12-16 | Buy |
Matrix Scientific | 063690 | 1-(1-Adamantyl)azepan-2-one | 500mg | $237 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|